Glioblastoma: Genetically Modified DeltEx Drug-Resistant Immunotherapy Gets Phase II Clinical Trial
From insulin to lowering environmental strain to grow food, genetic engineering is one of the marvels of the 20th century. In the 21st, CRISPR-Cas9 or something else may achieve the same lofty status…